Futura Medical (FUM) — Cash Flow Reinvestment Rate
Latest as of December 2024:
0.26x
Futura Medical (FUM) has a Cash Flow Reinvestment Rate of 0.26x as of December 2024, reinvesting GBX903.73K (capex GBX903.73K ) from operating cash flow of GBX3.44 Million. Check FUM cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
0.26x
(Capex + Investments) / Operating CF
Total Reinvested
GBX903.73K
Capex + Investments
Operating Cash Flow
GBX3.44 Million
GBX
Capital Expenditures
GBX903.73K
GBX
Futura Medical Cash Flow Reinvestment Rate (2023–2024)
Historical reinvestment intensity for Futura Medical across 2 annual periods. Explore Futura Medical cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Futura Medical (2023–2024)
Year-by-year capital reinvestment analysis for Futura Medical. For live market cap and broader valuation context, see FUM market cap overview.
| Year | Reinvestment Rate | Total Reinvested (GBX) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 7.77x | GBX3.41 Million | GBX438.41K | GBX1.73 Million | ▲ +50.7% |
| 2023 | 5.16x | GBX2.94 Million | GBX570.25K | GBX1.51 Million | — |
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow